Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Coffee

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos One|November 23, 2020
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)Thomas D Filardo, Maria R Khan, Noa Krawczyk, et al.
F1000Research|May 3, 2016
Open drug discovery for the Zika virusSean Ekins, Daniel Mietchen, Megan Coffee, et al.
PLOS Digital Health|February 22, 2023
To explain or not to explain?-Artificial intelligence explainability in clinical decision support systemsJulia Amann, Dennis Vetter, Stig Nikolaj Blomberg, et al.
Drug Discovery Today|April 23, 2020
Déjà vu: Stimulating open drug discovery for SARS-CoV-2Sean Ekins, Melina Mottin, Paulo R P S Ramos, et al.
Emerging Infectious Diseases|January 27, 2016
Prognostic Indicators for Ebola Patient SurvivalSamuel J Crowe, Matthew J Maenner, Solomon Kuah, et al.
IEEE Transactions on Technology and Society|December 27, 2022
Assessing Trustworthy AI in Times of COVID-19: Deep Learning for Predicting a Multiregional Score Conveying the Degree of Lung Compromise in COVID-19 PatientsHimanshi Allahabadi, Julia Amann, Isabelle Balot, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|November 23, 2020
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)Thomas D Filardo, Maria R Khan, Noa Krawczyk, et al.
F1000Research|May 3, 2016
Open drug discovery for the Zika virusSean Ekins, Daniel Mietchen, Megan Coffee, et al.
PLOS Digital Health|February 22, 2023
To explain or not to explain?-Artificial intelligence explainability in clinical decision support systemsJulia Amann, Dennis Vetter, Stig Nikolaj Blomberg, et al.
Drug Discovery Today|April 23, 2020
Déjà vu: Stimulating open drug discovery for SARS-CoV-2Sean Ekins, Melina Mottin, Paulo R P S Ramos, et al.
Emerging Infectious Diseases|January 27, 2016
Prognostic Indicators for Ebola Patient SurvivalSamuel J Crowe, Matthew J Maenner, Solomon Kuah, et al.
IEEE Transactions on Technology and Society|December 27, 2022
Assessing Trustworthy AI in Times of COVID-19: Deep Learning for Predicting a Multiregional Score Conveying the Degree of Lung Compromise in COVID-19 PatientsHimanshi Allahabadi, Julia Amann, Isabelle Balot, et al.
Pageof 2